文献速递浆细胞疾病

细胞遗传学异常对孤立性骨浆细胞瘤疾病进展风险的影响

Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas.
PubMed 文献 · Blood · 2023-01-01

该研究评估了梅奥诊所2012年1月至2022年7月诊断的114例孤立性骨浆细胞瘤(SBP)患者,其中55例有基线FISH结果,22例(40%)被归类为高危(HR)。HR FISH患者的中位进展至多发性骨髓瘤(MM)时间(TTP)为8个月(95%CI 6.3-26),而无HR FISH患者为42个月(95%CI 25-未达到)(P < .001)。多变量分析中,仅HR FISH是较短TTP的显著预测因素,独立于诊断时骨髓微小浸润和血清游离轻链比值异常。

要点

  • SBP患者中HR FISH阳性者中位TTP为8个月,阴性者为42个月(P < .001)。
  • HR FISH是较短TTP至MM的独立预测因素。
  • del(17p)和gain 1q是导致短TTP最常见FISH异常。

核心结论

  • 在克隆浆细胞中评估HR FISH异常(来自诊断性SBP组织或分期骨髓检查)可行,且可预测较短TTP至MM。

研究设计与样本

  • 回顾性队列研究,纳入梅奥诊所2012年1月至2022年7月诊断的114例SBP患者,其中55例(48%)有基线FISH结果。

主要发现

  • HR FISH患者中位TTP为8个月(95%CI 6.3-26),无HR FISH患者为42个月(95%CI 25-未达到)(P < .001)。
  • 多变量分析中,仅HR FISH是较短TTP至MM的显著预测因素,独立于诊断时骨髓微小浸润和血清游离轻链比值异常。
  • del(17p)和gain 1q是导致短TTP最常见FISH异常。

关键数值与推荐

  • FISH检测克隆浆细胞中del(17p)、t(14;16)、t(4;14)或+1q(增益或扩增)定义为HR。
  • 55例有基线FISH的患者中22例(40%)为HR。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Most patients with solitary bone plasmacytomas (SBP) progress to multiple myeloma (MM) after definitive radiation therapy as their primary treatment. Whether the presence of high-risk (HR) cytogenetic abnormalities by fluorescence in situ hybridization (FISH) in the clonal plasma cells, obtained either directly from the diagnostic SBP tissue or the corresponding bone marrow examination at the time of diagnosis, is associated with a shorter time to progression (TTP) to MM is unknown. This study evaluated all patients diagnosed with SBP at the Mayo Clinic from January 2012 to July 2022. The presence of del(17p), t(14;16), t(4;14), or +1q (gain or amplification) by FISH in clonal plasma cells was defined as HR. A total of 114 patients were included in this cohort, and baseline FISH was available for 55 patients (48%), of which 22 were classified as HR (40%). The median TTP to MM for patients with SBP and HR FISH was 8 months (95% confidence interval [CI], 6.3-26) compared with 42 months (95% CI, 25-not reached [NR]) in patients with SBP without HR FISH (P < .001). In a multivariate analysis, only HR FISH was a significant predictor for shorter TTP to MM, independent of minimal marrow involvement and an abnormal serum free light chain ratio at diagnosis. Deletion (17p) and gain 1q abnormalities were the most common FISH abnormalities responsible for the short TTP to MM. Thus, assessing for HR FISH abnormalities in clonal plasma cells derived from either the diagnostic SBP tissue or the staging bone marrow examination of patients with newly diagnosed SBP is feasible and prognostic for a shorter TTP to MM.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Yadav U, Kumar SK, Baughn LB, et al. Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas. Blood. 2023. PMID: 37494698. doi:10.1182/blood.2023021187

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。